Protagenic Therapeutics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PTIX research report →
Companywww.protagenic.com
Protagenic Therapeutics, Inc. , a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses.
- CEO
- Garo H. Armen
- IPO
- 2021
- Employees
- 1
- HQ
- New York City, NY, US
Price Chart
Valuation
- Market Cap
- $1.18M
- P/E
- -0.24
- P/S
- 0.00
- P/B
- -0.53
- EV/EBITDA
- -0.26
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 184.88%
- ROIC
- 379.69%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-5,156,250 · 6.67%
- EPS
- $-3.45 · -205.31%
- Op Income
- $-5,831,379
- FCF YoY
- 1.81%
Performance & Tape
- 52W High
- $7.11
- 52W Low
- $0.25
- 50D MA
- $0.64
- 200D MA
- $1.69
- Beta
- 0.47
- Avg Volume
- 6.85K
Get TickerSpark's AI analysis on PTIX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 15, 25 | EVANS BARRETT | other | 0 |
| May 15, 25 | EVANS BARRETT | other | 0 |
| May 15, 25 | EVANS BARRETT | other | 0 |
| May 15, 25 | EVANS BARRETT | other | 0 |
| May 15, 25 | EVANS BARRETT | other | 0 |
| Mar 25, 24 | WRIGHT TIMOTHY R | other | 21,250 |
| Mar 25, 24 | Stein Robert Benjamin | other | 75,000 |
| Mar 25, 24 | Barrage Khalil | other | 22,500 |
| Mar 25, 24 | Buell Jennifer | other | 75,000 |
| Mar 25, 24 | ARMEN GARO H | other | 250,000 |
Our PTIX Coverage
We haven't published any research on PTIX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PTIX Report →